Synthesis and in Vivo Evaluation of [123I] Melanin-Targeted Agents

…, RJ Hicks, A Katsifis, I Greguric

Index: Pham, Tien Q.; Greguric, Ivan; Liu, Xiang; Berghofer, Paula; Ballantyne, Patrice; Chapman, Janette; Mattner, Filomena; Dikic, Branko; Jackson, Timothy; Loc'h, Christian; Katsifis, Andrew Journal of Medicinal Chemistry, 2007 , vol. 50, # 15 p. 3561 - 3572

Full Text: HTML

Citation Number: 2

Abstract

This study reports the synthesis,[123I] radiolabeling, and biological profile of a new series of iodinated compounds for potential translation to the corresponding [131I] radiolabeled compounds for radionuclide therapy of melanoma. Radiolabeling was achieved via standard electrophilic iododestannylation in 60–90% radiochemical yield. Preliminary SPECT imaging demonstrated high and distinct tumor uptake of all compounds, as well as ...

Related Articles:

4-Acylamino-and 4-ureidobenzamides as melanin-concentrating hormone (MCH) receptor 1 antagonists

[Receveur, Jean-Marie; Bjurling, Emelie; Ulven, Trond; Little, Paul Brian; Norregaard, Pia K.; Hoegberg, Thomas Bioorganic and Medicinal Chemistry Letters, 2004 , vol. 14, # 20 p. 5075 - 5080]

Radioiodinated N-(2-diethylaminoethyl) benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization

[Eisenhut; Hull; Mohammed; Mier; Lay; Just; Gorgas; Lehmann; Haberkorn Journal of Medicinal Chemistry, 2000 , vol. 43, # 21 p. 3913 - 3922]

More Articles...